Prognosis of patients with intermediate-stage hepatocellular carcinomas based on the Child-Pugh score: Subclassifying the intermediate stage (Barcelona clinic liver cancer stage B)

Japanese Journal of Radiology

Volumn 32, Issue 11, 2014, Pages 644-649

  Yamakado, Koichiro ^a   Miyayama, Shiro ^b   Hirota, Shozo ^c   Mizunuma, Kimiyoshi ^d   Nakamura, Kenji ^e   Inaba, Yoshitaka ^f   Yamamoto, Satoshi ^c   Matsuo, Kunihiro ^g   Nishida, Norifumi ^h   Aramaki, Takeshi ⁱ   Anai, Hiroshi ^j   Kora, Shinichi ^k   Oikawa, Shigeo ^l   Watanabe, Ken ^m   Yasumoto, Taku ⁿ   Furuichi, Kinya ^o   Yamaguchi, Masato ^p  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUI KEN SAISEIKAI HOSPITAL   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d NASU RED CROSS HOSPITAL   (Japan)

^e Daito Central Hospital   (Japan)

^f AICHI CANCER CENTER HOSPITAL   (Japan)

^g Narumi Hospital   (Japan)

^h Osaka Prefecture University   (Japan)

ⁱ SHIZUOKA CANCER CENTER   (Japan)

^j NARA MEDICAL UNIVERSITY   (Japan)

^k FUKUOKA UNIVERSITY   (Japan)

^l Iwate Prefectural Central Hospital   (Japan)

^m JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ TOYONAKA MUNICIPAL HOSPITAL   (Japan)

^o Higashiosaka City General Hospital   (Japan)

^p KOBE UNIVERSITY   (Japan)

more..

Author keywords

Chemoembolization; Child Pugh score; Hepatocellular carcinoma; Prognosis; Stage

Indexed keywords

EPIRUBICIN; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD PUGH SCORE; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; CANCER GRADING; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; JAPAN; LIVER; LIVER NEOPLASMS; MIDDLE AGED; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; PROGNOSIS; RADIOGRAPHY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; JAPAN; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84911383202     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-014-0358-1     Document Type: Article

References (13)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.
2. de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. J Hepatol. 2012;56(Suppl 1):S75–87.
3. Bolondi L, Burroughs A, Dufour JF, Galle PR, Mazzaferro V, Piscaglia F, et al. Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis. 2012;32(4):348–59.
4. Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology. 2002;224:47–54.
5. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429–42.
6. Llovet JM, Real MI, Montan X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet. 2002;359:1734–9.
7. Yamakado K, Miyayama S, Hirota S, Mizunuma K, Nakamura K, Inaba Y, et al. Subgrouping of intermediate-stage (BCLC stage B) hepatocellular carcinoma based on tumor number and size and Child-Pugh grade correlated with prognosis after transarterial chemoembolization. Jpn J Radiol. 2014;32:260–5.
8. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10:35–43.
9. Piscaglia F, Terzi E, Cucchetti A, Trimarchi C, Granito A, Leoni S, et al. Treatment of hepatocellular carcinoma in Child-Pugh B patients. Dig Liver Dis. 2013;45:852–8.
10. Yamakado K, Miyayama S, Hirota S, Mizunuma K, Nakamura K, Inaba Y, et al. Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis? Jpn J Radiol. 2012;30:560–6.
11. Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.
12. Ha Y, Shim JH, Kim SO, Kim KM, Lim YS, Lee HC. Clinical appraisal of the recently proposed Barcelona clinic liver cancer stage B subclassification by survival analysis. J Gastroenterol Hepatol. 2014;29:787–93.
13. Cabibbo G, Maida M, Genco C, Parisi P, Peralta M, Antonucci M, et al. Natural history of untreatable hepatocellular carcinoma: a retrospective cohort study. World J Hepatol. 2012;27(4):256–61.